2004Journal of Pediatric PharmacyRequires access

The efficacy of amoxicillin/potassium clavulanate in treatment of respiratory infection

Zhu Ai-dong

Open publisher page 0 citations

Abstract

Objective: To evaluate the efficacy of amoxicillin/potassium clavulanate in control of respiratory infection. Methods: This was a single-blind, randomized control trial. Ninety-four patients with respiratory infection were randomly divided into experiment group and control group. Results: Between experiment group and control group, the effective rate was 89.58% and 89.13% respectively, the bacterial clearance rate was 95.00% and 89.13% respectively, side-effect rate was 8.3% and 6.52% respectively. Conclusion: Amoxicillin/potassium clavulanate is effective and well tolerated in the treatment of respiratory infection.

About this research paper

What this paper is about

Objective: To evaluate the efficacy of amoxicillin/potassium clavulanate in control of respiratory infection. Methods: This was a single-blind, randomized control trial. Ninety-four patients with respiratory infection were randomly divided into experiment group and control group. Results: Between experiment group and control group, the effective rate was 89.58% and 89.13% respectively, the bacterial clearance rate was 95.00% and 89.13% respectively, side-effect rate was 8.3% and 6.52% respectively. Conclusion: Amoxicillin/potassium clavulanate is effective and well tolerated in the treatment of respiratory infection.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To evaluate the efficacy of amoxicillin/potassium clavulanate in control of respiratory infection. Methods: This was a single-blind, randomized control trial. Ninety-four patients with respiratory infection were randomly divided into experiment group and control group. Results: Between experiment group and control group, the effective rate was 89.58% and 89.13% respectively, the bacterial clearance rate was 95.00% and 89.13% respectively, side-effect rate was 8.3% and 6.52% respectively. Conclusion: Amoxicillin/potassium clavulanate is effective and well tolerated in the treatment of respiratory infection.

Key concepts: Medicine, Amoxicillin, Respiratory system, Internal medicine, Randomized controlled trial, Respiratory infection, Potassium, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
The efficacy of amoxicillin/potassium clavulanate in treatment of respiratory infection — Research Paper | ScholarLens